TABLE 4.

Quantitative analysis of cell-free HHV-8 DNA in 26 patients with various HHV-8-associated diseases

Patient no.	HHV-8-associated disease(s)	Sample (vol in μl)	Amt of HHV-8 (copies/r)	Calibrator recovery (%)	No. of HHV-8 genome equivalents/ml		HHV-8 antibody titer
					Uncalibrated	Calibrated
1	AIDS-KSa	Serum (200)	140	36	7,000	19,440	1:1,280
2		Serum (200)	14	25	700	2,800	1:320
3		Serum (200)	0	46	0	<109	>1:1,280
4		Serum (200)	0	100	0	<50	<1:20
5		Serum (200)	8	100	400	400	>1:1,280
6	AIDS-KSb	Plasma (500)	38	71	750	1,070	>1:1,280
7		Plasma (1,000)	78	32	780	2,450	>1:1,280
8		Plasma (1,000)	1	51	10	20	>1:1,280
9		Plasma (500)	2	80	40	50	>1:1,280
10		Plasma (500)	28,000	100	560,000	560,000	>1:1,280
11		Plasma (1,000)	1	100	10	10	>1:1,280
12		Plasma (1,000)	100	48	1,000	2,080	>1:1,280
13		Plasma (1,000)	93	35	930	2,660	>1:1,280
14		Plasma (1,000)	1	100	10	10	>1:1,280
15		Plasma (1,000)	3	100	30	30	>1:1,280
16		Plasma (1,000)	3	26	30	115	>1:1,280
17		Plasma (1,000)	1	94	10	11	>1:1,280
18		Plasma (1,000)	0	15	0	<66	>1:1,280
19	HIV+/HHV-8+	Plasma (1,000)	5	50	50	100	1:3,560
20		Plasma (1,000)	7	50	70	140	1:640
21	Classical KS	Plasma (500)	30	30	300	2,000	1:320
22		Plasma (1,000)	20	100	200	200	1:1,280
23	Post-transplantation KS	Plasma (1,000)	0	100	0	<10	1:1,280
24		Plasma (1,000)	11	65	110	168	1:1,280
25	AIDS-BCL	Plasma (1,000)	6	40	60	150	>1:1,280
26	AIDS-MCD	Plasma (500)	111	72	2,220	3,080	>1:1,280

^aPatients from Uganda.

^bPatients from Europe.